Durvalumab is an IV drug that boosts the immune system’s ability to detect and kill cancer cells. It’s used to treat a range ...

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), ...

A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits. Dr. Kevin Liou presented the results of ...

Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online in ...

NYC for MSK Participating Locations NYC for MSK 2025 Over 100 Participating Locations NEW YORK, NY, UNITED STATES, May 29, 20 ...

Music therapy appeared as effective as first-line cognitive behavioral therapy for reduction of anxiety among cancer ...

At Memorial Sloan Kettering Cancer Center (MSK), neurosurgeon Nelson Moss, MD, Co-Director of the Multidisciplinary Brain Metastasis Program, and radiation oncologist and early drug development ...